JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCabe, M. J.
Right arrow Articles by States, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCabe, M. J., Jr.
Right arrow Articles by States, J. C.

Vol. 295, Issue 2, 724-733, November 2000

Sensitivity of Myelomonocytic Leukemia Cells to Arsenite-Induced Cell Cycle Disruption, Apoptosis, and Enhanced Differentiation Is Dependent on the Inter-Relationship between Arsenic Concentration, Duration of Treatment, and Cell Cycle Phase1

Michael J. McCabe, Jr.2 , Kameshwar P. Singh, Srikar A. Reddy, Bhadrani Chelladurai, Joel G. Pounds3 , John J. Reiners, Jr. and J. Christopher States4

Institute of Chemical Toxicology (M.J.M., K.P.S., S.A.R., B.C., J.G.P., J.J.R., J.C.S.) and Department of Pharmaceutical Sciences (M.J.M., J.G.P., J.C.S.), Wayne State University, Detroit, Michigan

Arsenite treatment has been found to induce clinical remission in patients with acute promyelocytic leukemia. Although the potential therapeutic value of arsenite may lie in triggering apoptosis, it has not been established that cytotoxicity is the sole mechanism of action. We have used a myelomonocytic leukemia cell line (U937) to characterize the concentration-dependent effects of arsenite on cell growth, viability, apoptosis, and differentiation. Arsenite has multiple effects on U937 cells. Low concentrations of arsenite (i.e., <= 1 µM) potentiate vitamin-D3-induced differentiation. Two markers of monocyte differentiation, Mac-1 expression and nitroblue tetrazolium reduction, are increased in arsenite-exposed, D3-costimulated cells. Concentrations of arsenite >10 µM rapidly induce the death of cells irrespective of cell cycle phase. Intermediate concentrations of arsenite (i.e., 5 to 10 µM) are cytostatic initially. Cell cycle analysis using elutriated, synchronous cell populations revealed that intermediate concentrations of arsenite delay both G1 and G2 transit. G2 cells appear to be most sensitive to arsenite, in that transit through G2/M is more delayed than transit through G1, and apoptosis is induced in these cells as they emerge from an aberrant G2/M. Arsenite-induced apoptosis was caspase-3 dependent. Arsenite-mediated cytotoxicity was reduced in the presence of the broad caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone; however, caspase inhibition did not reverse arsenite-induced cytostasis. Thus, arsenite has multiple effects on U937 cells that are dependent on concentration and cell cycle phase. Specifically, cell cycle transit and differentiation are more sensitive to arsenite than is the induction of apoptosis.

1 This work was supported in part by a pilot project awarded through the National Institutes of Health Environmental Health Sciences Center Grant P30 ES06639 and by an Interdisciplinary Research Seed Fund awarded through the Office of Research and Sponsored Programs at Wayne State University. S.A.R. was supported, in part, by the high school student apprenticeship Grant R25 RR12242. K.P.S. was supported, in part, by R01 ES09392.

2 Present address: Michael J. McCabe, Jr., Department of Environmental Medicine, University of Rochester School of Medicine, 575 Elmwood Ave., Box EHSC, Rochester, NY 14642.

3 Present address: Joel G. Pounds, Molecular Biosciences Department, Pacific Northwest National Laboratory, P.O. Box 999, Mail Stop P7-58, Richland, WA 99352.

4 Present address: J. Christopher States, Department of Pharmacology & Toxicology, University of Louisville School of Medicine, 570 S. Preston St., Suite 221 Louisville, KY 40292.

0022-3565/00/2952-0724$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Toxicol SciHome page
G. M. Lehmann and M. J. McCabe Jr
Arsenite Slows S Phase Progression via Inhibition of cdc25A Dual Specificity Phosphatase Gene Transcription
Toxicol. Sci., September 1, 2007; 99(1): 70 - 78.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Zhang, L. Song, J. Li, K. Wu, and C. Huang
Coordination of JNK1 and JNK2 Is Critical for GADD45{alpha} Induction and Its Mediated Cell Apoptosis in Arsenite Responses
J. Biol. Chem., November 10, 2006; 281(45): 34113 - 34123.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. F. Taylor, S. C. McNeely, H. L. Miller, G. M. Lehmann, M. J. McCabe Jr., and J. C. States
p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 142 - 151.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. S. Sidhu, R. A. Ponce, M. A. Vredevoogd, X. Yu, E. Gribble, S.-W. Hong, E. Schneider, and E. M. Faustman
Cell Cycle Inhibition by Sodium Arsenite in Primary Embryonic Rat Midbrain Neuroepithelial Cells
Toxicol. Sci., February 1, 2006; 89(2): 475 - 484.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J.-P. Li, J.-C. Lin, and J.-L. Yang
ERK Activation in Arsenite-Treated G1-Enriched CL3 Cells Contributes to Survival, DNA Repair Inhibition, and Micronucleus Formation
Toxicol. Sci., January 1, 2006; 89(1): 164 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
E. Dopp, L. M. Hartmann, U. von Recklinghausen, A. M. Florea, S. Rabieh, U. Zimmermann, B. Shokouhi, S. Yadav, A. V. Hirner, and A. W. Rettenmeier
Forced Uptake of Trivalent and Pentavalent Methylated and Inorganic Arsenic and Its Cyto-/genotoxicity in Fibroblasts and Hepatoma Cells
Toxicol. Sci., September 1, 2005; 87(1): 46 - 56.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. McCollum, P. C. Keng, J. C. States, and M. J. McCabe Jr.
Arsenite Delays Progression through Each Cell Cycle Phase and Induces Apoptosis following G2/M Arrest in U937 Myeloid Leukemia Cells
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 877 - 887.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. P. Santini, S. Myrand, C. Elferink, and J. J. Reiners Jr.
Regulation of Cyp1a1 Induction by Dioxin as a Function of Cell Cycle Phase
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 718 - 728.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.